Atlas Venture Opportunity Fund II Filings

D

$300M in investment fund, sold $300M, 69 investors

1 Oct 21

4

Korro Bio, Inc.

23 Apr 24

3

Q32 Bio Inc.

27 Mar 24

4

Dyne Therapeutics, Inc.

5 Mar 24

144

Dyne Therapeutics, Inc.

1 Mar 24

4

Dyne Therapeutics, Inc.

28 Feb 24

4

Dyne Therapeutics, Inc.

23 Feb 24

144

Dyne Therapeutics, Inc.

23 Feb 24

4

Disc Medicine, Inc.

25 Jan 24

144

Disc Medicine, Inc.

23 Jan 24

3

Korro Bio, Inc.

7 Nov 23

3

Disc Medicine, Inc.

3 Jan 23

4

Dyne Therapeutics, Inc.

14 Dec 22

4

Day One Biopharmaceuticals, Inc.

22 Jun 22